INEO Tech appoints David Wambeke to its board of directors

INEO Tech Corp. (TSXV: INEO)(OTCQB: INEOF)(FSE: 0OQ) has appointed David Wambeke to its board of directors, the company announced in a press release.

Wambeke currently serves as Chief Business Officer of NeuroOne Medical Technologies Corporation and previously held the same title at DiaMedica Therapeutics Inc. Before entering the corporate sector, he spent approximately 16 years at Craig-Hallum Capital Group, where he rose to Managing Director and Partner. During his investment banking career, he executed more than $5 billion in merger and acquisition transactions, equity financings, debt placements, and fairness opinions, and led more than 200 equity capital markets financings.

Wambeke holds approximately 19.9% of INEO's outstanding common shares. "Dave has already been a valuable resource to INEO as a significant shareholder, and we are very pleased to have him join the Board formally," said Greg Watkin, Chairman and Founder of INEO.

Wambeke holds a Bachelor of Science in Finance and Economics from the University of Minnesota and served in the United States Army, including a combat deployment in Baghdad, Iraq, where he was awarded the Purple Heart.

INEO Tech Corp. is headquartered in Surrey, British Columbia, and develops connected entrance infrastructure for retail locations.

You May Also Be Interested In

• Piper Sandler Resumes Supernus Pharmaceuticals (SUPN) at Overweight
• AudioCodes Ltd. (AUDC) Reports In-Line Q3 EPS
• JPMorgan Downgrades Group 1 Automotive Inc. (GPI) to Underweight